Arkolith/Insider Trading/SCPH/Form 4

OrbiMed Capital GP VI LLC

10% OwnerscPharmaceuticals Inc. (SCPH) · full profile →Form 4 · filed Aug 15, 2024
Net Buying
Open-Market Buys
$2.0M
Open-Market Sells
$0
Net Open-Market Flow
$2.0M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 13, 2024Buy(P)22K$4.00$87K253K
Aug 13, 2024Buy(P)478K$4.00$1.9M5.8M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000947871-24-000701) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML